BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 27298334)

  • 21. Loss of tyrosine catabolic enzyme HPD promotes glutamine anaplerosis through mTOR signaling in liver cancer.
    Tong M; Wong TL; Zhao H; Zheng Y; Xie YN; Li CH; Zhou L; Che N; Yun JP; Man K; Lee TK; Cai Z; Ma S
    Cell Rep; 2021 Aug; 36(8):109617. PubMed ID: 34433044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of the Potential Metabolic Pathways Involved in the Hepatic Tumorigenesis of Rat Diethylnitrosamine-Induced Hepatocellular Carcinoma via
    Chen M; Lu S; Zheng H; Xu M; Song J; Yang W; Weng Q; Zheng L; Fan X; Cheng X; Gao H; Ji J
    Biomed Res Int; 2019; 2019():9367082. PubMed ID: 30719453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The mTORC1 pathway stimulates glutamine metabolism and cell proliferation by repressing SIRT4.
    Csibi A; Fendt SM; Li C; Poulogiannis G; Choo AY; Chapski DJ; Jeong SM; Dempsey JM; Parkhitko A; Morrison T; Henske EP; Haigis MC; Cantley LC; Stephanopoulos G; Yu J; Blenis J
    Cell; 2013 May; 153(4):840-54. PubMed ID: 23663782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glutamine, MTOR and autophagy: a multiconnection relationship.
    Bodineau C; Tomé M; Murdoch PDS; Durán RV
    Autophagy; 2022 Nov; 18(11):2749-2750. PubMed ID: 35470752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting hepatic glutaminase activity to ameliorate hyperglycemia.
    Miller RA; Shi Y; Lu W; Pirman DA; Jatkar A; Blatnik M; Wu H; Cárdenas C; Wan M; Foskett JK; Park JO; Zhang Y; Holland WL; Rabinowitz JD; Birnbaum MJ
    Nat Med; 2018 May; 24(4):518-524. PubMed ID: 29578539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nuclear-mitochondrial crosstalk: On the role of the nuclear receptor liver receptor homolog-1 (NR5A2) in the regulation of mitochondrial metabolism, cell survival, and cancer.
    Michalek S; Brunner T
    IUBMB Life; 2021 Mar; 73(3):592-610. PubMed ID: 32931651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Asparagine promotes cancer cell proliferation through use as an amino acid exchange factor.
    Krall AS; Xu S; Graeber TG; Braas D; Christofk HR
    Nat Commun; 2016 Apr; 7():11457. PubMed ID: 27126896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disrupting Mitochondrial Pyruvate Uptake Directs Glutamine into the TCA Cycle away from Glutathione Synthesis and Impairs Hepatocellular Tumorigenesis.
    Tompkins SC; Sheldon RD; Rauckhorst AJ; Noterman MF; Solst SR; Buchanan JL; Mapuskar KA; Pewa AD; Gray LR; Oonthonpan L; Sharma A; Scerbo DA; Dupuy AJ; Spitz DR; Taylor EB
    Cell Rep; 2019 Sep; 28(10):2608-2619.e6. PubMed ID: 31484072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolism. Differential regulation of mTORC1 by leucine and glutamine.
    Jewell JL; Kim YC; Russell RC; Yu FX; Park HW; Plouffe SW; Tagliabracci VS; Guan KL
    Science; 2015 Jan; 347(6218):194-8. PubMed ID: 25567907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conditional overexpression of liver receptor homolog-1 in female mouse mammary epithelium results in altered mammary morphogenesis via the induction of TGF-β.
    Lazarus KA; Brown KA; Young MJ; Zhao Z; Coulson RS; Chand AL; Clyne CD
    Endocrinology; 2014 May; 155(5):1606-17. PubMed ID: 24564400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anabolic SIRT4 Exerts Retrograde Control over TORC1 Signaling by Glutamine Sparing in the Mitochondria.
    Shaw E; Talwadekar M; Rashida Z; Mohan N; Acharya A; Khatri S; Laxman S; Kolthur-Seetharam U
    Mol Cell Biol; 2020 Jan; 40(2):. PubMed ID: 31685549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amino acids fuel T cell-mediated inflammation.
    Poffenberger MC; Jones RG
    Immunity; 2014 May; 40(5):635-7. PubMed ID: 24837098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GLS2 Is a Tumor Suppressor and a Regulator of Ferroptosis in Hepatocellular Carcinoma.
    Suzuki S; Venkatesh D; Kanda H; Nakayama A; Hosokawa H; Lee E; Miki T; Stockwell BR; Yokote K; Tanaka T; Prives C
    Cancer Res; 2022 Sep; 82(18):3209-3222. PubMed ID: 35895807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting ASCT2-mediated glutamine uptake blocks prostate cancer growth and tumour development.
    Wang Q; Hardie RA; Hoy AJ; van Geldermalsen M; Gao D; Fazli L; Sadowski MC; Balaban S; Schreuder M; Nagarajah R; Wong JJ; Metierre C; Pinello N; Otte NJ; Lehman ML; Gleave M; Nelson CC; Bailey CG; Ritchie W; Rasko JE; Holst J
    J Pathol; 2015 Jul; 236(3):278-89. PubMed ID: 25693838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ω-Amidase: an underappreciated, but important enzyme in L-glutamine and L-asparagine metabolism; relevance to sulfur and nitrogen metabolism, tumor biology and hyperammonemic diseases.
    Cooper AJ; Shurubor YI; Dorai T; Pinto JT; Isakova EP; Deryabina YI; Denton TT; Krasnikov BF
    Amino Acids; 2016 Jan; 48(1):1-20. PubMed ID: 26259930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver receptor homolog-1 (NR5a2) regulates CD95/Fas ligand transcription and associated T-cell effector functions.
    Schwaderer J; Gaiser AK; Phan TS; Delgado ME; Brunner T
    Cell Death Dis; 2017 Apr; 8(4):e2745. PubMed ID: 28406481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver-Type Glutaminase GLS2 Is a Druggable Metabolic Node in Luminal-Subtype Breast Cancer.
    Lukey MJ; Cluntun AA; Katt WP; Lin MJ; Druso JE; Ramachandran S; Erickson JW; Le HH; Wang ZE; Blank B; Greene KS; Cerione RA
    Cell Rep; 2019 Oct; 29(1):76-88.e7. PubMed ID: 31577957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glutamine synthetase and glutaminase activities in various hepatoma cells.
    Matsuno T; Hirai H
    Biochem Int; 1989 Aug; 19(2):219-25. PubMed ID: 2573354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species.
    Suzuki S; Tanaka T; Poyurovsky MV; Nagano H; Mayama T; Ohkubo S; Lokshin M; Hosokawa H; Nakayama T; Suzuki Y; Sugano S; Sato E; Nagao T; Yokote K; Tatsuno I; Prives C
    Proc Natl Acad Sci U S A; 2010 Apr; 107(16):7461-6. PubMed ID: 20351271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Silencing LRH-1 in colon cancer cell lines impairs proliferation and alters gene expression programs.
    Bayrer JR; Mukkamala S; Sablin EP; Webb P; Fletterick RJ
    Proc Natl Acad Sci U S A; 2015 Feb; 112(8):2467-72. PubMed ID: 25675535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.